Georgios Ntentas
BSc, MSc, DPhil
Early Career Research Fellow - Senior Medical Physicist
Georgios Ntentas is a Medical Physics Research Fellow at Oxford Population Health. He also holds an NIHR Clinical Lectureship at Guy’s and St Thomas’ Hospital NHS Foundation Trust and King's College London.
Georgios is a senior radiotherapy physicist and his main research interest is investigating the early and late effects of chemotherapy and radiotherapy and particularly chemotherapy- and radiation-related cardiovascular toxicities and second cancers.
He is working on collaborative research projects between Oxford University and the Dutch National Cancer Institute on a cohort of Hodgkin Lymphoma survivors investigating the late effects of radiotherapy.
Georgios is also investigating the potential benefits and risks of proton beam therapy for lymphoma patients amongst other projects. Other research interests include radio-ablation for Ventricular Tachycardia, advanced radiation treatment planning techniques for lymphoma and esophageal cancers.
Georgios holds a DPhil in Population Health from the University of Oxford, two Masters degrees in Clinical Sciences and Medical Physics from King’s College London and the University of Surrey respectively and a BSc in Nuclear Physics from Aristotle University, Greece.
Recent publications
-
Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015-2023.
Journal article
Holt F. et al, (2024), Clin Oncol (R Coll Radiol), 36, e322 - e332
-
Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.
Journal article
Jones DA. et al, (2023), Clin Oncol (R Coll Radiol), 35, 301 - 310
-
Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.
Journal article
Ntentas G. et al, (2022), Int J Radiat Oncol Biol Phys, 112, 913 - 925
-
Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry.
Journal article
Jones DA. et al, (2022), Blood Adv, 6, 909 - 919
-
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma.
Journal article
Cutter DJ. et al, (2021), J Clin Oncol, 39, 3591 - 3601